The main finding of our study is that four proteins (IL-6, PAR1, TNFRSF11A and Gal-9) are linked to cardiovascular outcomes in PAD patients and therefore are novel candidate biomarkers for risk assessment in PAD. The gene discussed is F2R; the disease is peripheral arterial disease.